| Financial Year |
March 31 2023 |
| Monetary Funds |
491,944,295.64 |
| Held-for-trading Financial Assets |
175,348,082.19 |
| Notes Receivable |
11,993,605.86 |
| Accounts Receivable |
772,769,503.71 |
| Advances to Suppliers |
9,055,500.10 |
| Other Receivables |
1,366,288.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,545,418.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,893,196.24 |
| Total Current Assets |
1,641,915,890.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,704,897.55 |
| Investment Properties |
-- |
| Fixed Assetes |
282,611,841.47 |
| Under-construction Projects |
160,969,041.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,242,388.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,999,809.73 |
| Deferred Income Tax Assets |
10,851,615.18 |
| Other Non-Current Assets |
20,290,835.88 |
| Sub-Total of Non-Current Assets |
563,372,698.27 |
| Total Assets |
2,205,288,588.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
187,284,101.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,759,599.40 |
| Taxes Payable |
9,934,658.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
300,500.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,775,264.74 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
209,563,943.22 |
| Long-term Loans |
15,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
61,230,917.39 |
| Total Liabilities |
270,794,860.61 |
| Paid-In Capital(Or Share Stock) |
293,156,493.00 |
| Capital Surplus |
812,481,748.23 |
| Surplus Reserve |
92,705,976.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
721,481,448.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,934,493,727.81 |
| Owner's Equity（Stockholder's Equity） |
1,934,493,727.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,205,288,588.42 |
